Simplex Trading
PRCT icon

Simplex Trading’s Procept Biorobotics PRCT Stock Holding History

Simplex Trading’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.9K Sell
3,895
-12,830
-77% -$321K ﹤0.01% 5711
2026
Q1 		$418K Buy
16,725
+10,086
+152% +$284K ﹤0.01% 3485
2025
Q4 		$209K Buy
6,639
+5,303
+397% +$176K ﹤0.01% 4192
2025
Q3 		$47K Sell
1,336
-396
-23% -$18.1K ﹤0.01% 6521
2025
Q2 		$99K Sell
1,732
-4,790
-73% -$271K ﹤0.01% 5249
2025
Q1 		$379K Buy
+6,522
New +$445K ﹤0.01% 3700
2024
Q1 		– Sell
-29,085
Closed -$1.38M – 9652
2023
Q4 		$1.22M Buy
29,085
+9,247
+47% +$315K ﹤0.01% 2829
2023
Q3 		$650K Buy
19,838
+6,306
+47% +$215K ﹤0.01% 3114
2023
Q2 		$478K Buy
13,532
+12,128
+864% +$401K ﹤0.01% 3364
2023
Q1 		$39K Buy
+1,404
New +$49.5K ﹤0.01% 6207

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Simplex Trading's PRCT Position: Q2 2026 in Review

Simplex Trading reduced its Procept Biorobotics (PRCT) stake by 77% in Q2 2026, selling an estimated $321K and leaving 3,895 shares worth $87.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5711.

Simplex Trading first reported a position in PRCT in Q1 2023 and has held it in 10 quarters since. The position peaked at $1.22M in Q4 2023. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Simplex Trading held 3,895 shares of Procept Biorobotics worth $87.9K as of Q2 2026.
  • Simplex Trading sold 12,830 Procept Biorobotics shares in Q2 2026, an estimated $321K.
  • Procept Biorobotics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5711 holding.
  • Simplex Trading first reported a position in Procept Biorobotics in Q1 2023 and has held it in 10 quarters since.
  • Simplex Trading's Procept Biorobotics position peaked at $1.22M in Q4 2023.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.